-
Hualong No. 1 nuclear grade cable research and development in harsh environment successfully filled the domestic gap
Time of Update: 2022-11-19
Hualong No. 1 Class 1E Cable Achievement (Product) Appraisal Meeting siteHualong No. 1 Class 1E harsh environment cable is one of the important supporting products of nuclear power plants, mainly used in nuclear power transmission, control and measurement systems, is the main artery to ensure the normal operation of each system.
-
Bispecific antibodies for ophthalmology! Two Phase 3 studies of Vabysmo for retinal vein occlusion (RVO) were successful
Time of Update: 2022-11-05
Levi Garraway, Roche's Chief Medical Officer and Head of Global Product Development, said: "These encouraging data suggest that Vabysmo has the potential to offer a new treatment option for patients with retinal vein occlusion (RVO), a serious retinal vascular disease that can lead to irreversible visual impairment or vision loss.
-
Nanchang Market Supervision Administration 2022 Food Sampling Inspection Information Notice (No. 45 of 2022
Time of Update: 2022-10-25
In accordance with the Food Safety Law of the People's Republic of China and other relevant regulations, the food safety sampling inspection information recently carried out by our bureau is hereby a
-
Types of hernia and their imaging characteristics
Time of Update: 2022-10-02
Note widening of the temporal angle of the contralateral ventricle (*)Schematic of laterally descending cerebellar curtain hiatus hernia with compression of the posterior cerebral artery (white short arrow), compression of the oculomotor nerve (black short arrow), attention to ipsilateral pupil dilation (black long arrow), contralateral ventricular temporal angle dilation (*).
-
Induction therapy with ibrutinib and rituximab is safe and effective in young patients with newly diagnosed MCL: the WINDOW-1 study
Time of Update: 2022-04-28
Table 1: Baseline Characteristics of Patients in the WINDOW-1 Study Patient Short-Term Response Patients received a median of 7 cycles of treatment in Part A and 4 cycles in Part B.
-
The four departments of Qingdao will carry out joint law enforcement to ensure the quality and safety of aquatic products and crack down on the excessive use of pesticides, etc
Time of Update: 2022-02-17
In order to "prevent, control, and manage strictly" the quality and safety risks of aquatic products in Qingdao, and ensure the "safety on the tip of the tongue" of the people, on the afternoon of Feb
-
Stroke: After a stroke, how do serious adverse events affect the functional outcome
Time of Update: 2021-09-19
In the post-hoc analysis of this WAKE-UP trial, Iris Lettow of Universitätsklinikum Hamburg-Eppendorf and others explored the impact of SAE on functional outcomes after 90 days and determined baseline characteristics that may predict the occurrence of SAE in patients with acute stroke .
-
Notice of Jiangxi Provincial Market Supervision Administration on 3 batches of unqualified foods (No. 17 of 2021
Time of Update: 2021-05-20
html" class="zdbq" title="Puffed food related food information" target="_blank">food in 11 major categories of food, and 3 batches of beverages were found to be unqualified, which involved foodmate.
-
The eight new drugs were approved in China from AstraZeneta, Hesco and other companies
Time of Update: 2021-03-09
According to the CDE Priority Review Public Information, The new adaptive disorder approved by Dagrid Net this time is - for adult patients with reduced blood test scores for heart failure (HFrEF), reducing the risk of cardiovascular death and worsening heart failure, and improving heart failure symptoms.
-
Genfit's double agonist was awarded orphan drug status by the FDA and EMA
Time of Update: 2021-02-24
April 2019, the FDA also awarded Elafibranor Breakthrough Drug Qualification (BTD) for the treatment of adult PBC patients who did not respond well to UDCA.
Genfit plans to launch Phase III clinical studies in 2019 to further evaluate the efficacy and safety of elafibranor's treatment of PBC.
-
Announcement of the Beijing Municipal Market Supervision Administration on food safety supervision and sampling information for 2019 (No. 28 of 2019
Time of Update: 2021-01-17
In accordance with the requirements of the Food Safety Law of the People's Republic of China and other laws and regulations, as well as the city's food safety supervision and sampling plan and the cor
-
Exposure safety Akebia's Vadadustat Phase III trial of chronic kidney anemia failed
Time of Update: 2020-09-19
pro2TECT has two studies, Correction and Conversion, designed to compare the effectiveness and safety of vadadustat with Aranesp, which is used to treat chronic kidney disease (CKD) anemia in adults.
-
FDA Grants AstraZeneca MEDI8897 Breakthrough Treatment Designation
Time of Update: 2020-06-10
, pharmaceutical (http:// giant AstraZeneca announced that the u.S Food and Drug (http:// Administration ( FDA (http:// ) has granted MEDI8897 breakthrough treatment designation (BTD) In Marc
-
Registration and classification of new chemical drugs have been implemented, and all kinds of applications have been surging
Time of Update: 2020-04-03
On July 11, CDE undertook the first class 1 new drug declared according to the registration and classification of new chemicals On July 26, CDE undertook the first category 5.1 and 5.2 imported drugs
-
Technical status and future development trend of drying equipment
Time of Update: 2017-04-06
With the joint efforts of engineering and technical personnel in drying industry, drying equipment in China has made great progress in recent years The structure and performance of the dryer have been
